Comprehensive Intensive Stroke Rehabilitation

Summary

In this study, the investigators aim to assess the effectiveness of the Comprehensive Intensive Rehabilitation Program After Stroke implementing the International Classification of Functioning, Disability and Health model, and to compare it with two cohorts receiving Comprehensive Intensive Rehabilitation Program After Stroke of the same length but different in physical therapy content (program implementing modern technological approach and neuroproprioceptive "facilitation and inhibition"). Moreover, control group will undergo standard care.

Conditions

• Stroke
• Rehabilitation
• Physical Therapy Modalities

Interventions

BEHAVIORAL

Neuroproprioceptive "facilitation, inhibition"

Participants will undergo a standard comprehensive intensive rehabilitation program three hours a day for three weeks and moreover one hour a day of neuroproprioceptive "facilitation, inhibition" physical therapy.

BEHAVIORAL

Technology based physical therapy

Participants will undergo a standard comprehensive intensive rehabilitation program three hours a day for three weeks and moreover one hour a day of technology based physical therapy.

BEHAVIORAL

Effectively managed rehabilitation implementing the recommendations of the World Health Organization

Participants will undergo a four hour a day for three weeks of effectively managed comprehensive intensive rehabilitation implementing the recommendations of the World Health Organization.

BEHAVIORAL

Standard care

Participants will undergo standardly provided care including face to face physiotherapy (bed mobility, transfers, gait, therapeutic exercises, positioning, education).

Sponsors & Collaborators

• Thomayer University Hospital

  collaborator OTHER

• Academy of Science Czech Republic

  collaborator UNKNOWN

• Ministry of Health, Czech Republic

  collaborator OTHER_GOV

• Vascular surgery, University hospital Královské Vinohrady, Prague

  collaborator OTHER

• Charles University, Czech Republic

  lead OTHER

Principal Investigators

• Kamila Řasová, Dr. · Third Faculty of Medicine Charles University

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-05-01

Primary Completion

2025-06-15

Completion

2026-01-15

Countries

• Czechia

Study Locations